ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2010
The dynamics of colorectal cancer management in 17 countries.
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Educational interventions to improve bowel cancer awareness and screening in Organisation for Economic Co-operation and Development countries: A scoping review.Preventive medicine reports · 2024Article
- The Impact of Hematologic Parameters on Histopathologic Features of Colorectal Cancer.International journal of general medicine · 2024Article
- How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?Healthcare (Basel, Switzerland) · 2022Article
- Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study.Frontiers in oncology · 2021Article
- International evaluation of circumferential resection margins after rectal cancer resection: insights from the Swedish and Dutch audits.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2020Article
- Provider Costs of Treating Colorectal Cancer in Government Hospital of Malaysia.The Malaysian journal of medical sciences : MJMS · 2019Article
- Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.International journal of cancer · 2018Article
- Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.Frontiers in public health · 2018Review
- Article
- The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis.Oncotarget · 2017Article
- Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.BMJ (Clinical research ed.) · 2015Article
- Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.Pathology oncology research : POR · 2015Article
- SALL4 as a new biomarker for early colorectal cancers.Journal of cancer research and clinical oncology · 2015Article
- The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening.The European journal of health economics : HEPAC : health economics in prevention and care · 2014Article
- How might healthcare systems influence speed of cancer diagnosis: a narrative review.Social science & medicine (1982) · 2014Article
- Public stated preferences and predicted uptake for genome-based colorectal cancer screening.BMC medical informatics and decision making · 2014Article
- Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany.PloS one · 2014Article
- miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis.Omics : a journal of integrative biology · 2014Article
- How much does it cost to care for survivors of colorectal cancer? Caregiver's time, travel and out-of-pocket costs.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2013Article
- Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.BMC health services research · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper discusses the current care management arrangements for colorectal cancer (CRC) in 16 OECD countries plus the Russian Federation by analysing data sources, the uptake of screening and surveillance, the available capacity in endoscopy services, the treatment pathways in medical treatment, as well as the type and availability of pharmaceutical care. The paper highlights significant variations in practice across the 17 countries. Common themes emerge from each of these practices and standards in terms of political interest in policies and awareness of CRC (both of which need to be enhanced), affordability (in terms of scarcity of resources in some countries and out-of-pocket payments for parts of the overall treatment process), access (in terms of the significant variation that has been observed within and across countries with regard to diagnostics, treatment and certain pharmaceuticals) and quality of CRC services (which may arise due to variations in treatment and pharmaceutical guidelines as well as minimal monitoring). When considering policy options for the future, it is important to, first, improve data collection both within as well as across countries through international co-operation; second, it is critical to have greater national and international support for cancer screening activities proven to be effective and cost-effective; third, endoscopy capacity in individual countries needs to be improved, also allowing more choice to ensure timely diagnosis, regardless of screening activities; fourth, public and political awareness needs to be enhanced as it is the key to improving CRC outcomes; fifth, where appropriate, to give consideration to the principles of equity, human dignity and disease severity, among others, when deciding on the uptake of new (targeted) treatments, rather than base decisions solely on cost-effectiveness criteria; and sixth, to firm up national guidelines including screening, diagnosis, treatment, pharmaceutical treatments and surveillance, with a view to enhancing their timeliness, evidence-base and free access to all.
Indexed as
Identifiers
20012129What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.